NO20002149D0 - FremgangsmÕte for Õ redusere avhengighet hos pattedyr - Google Patents

FremgangsmÕte for Õ redusere avhengighet hos pattedyr

Info

Publication number
NO20002149D0
NO20002149D0 NO20002149A NO20002149A NO20002149D0 NO 20002149 D0 NO20002149 D0 NO 20002149D0 NO 20002149 A NO20002149 A NO 20002149A NO 20002149 A NO20002149 A NO 20002149A NO 20002149 D0 NO20002149 D0 NO 20002149D0
Authority
NO
Norway
Prior art keywords
addiction
procedure
reducing mammalian
mammalian
reducing
Prior art date
Application number
NO20002149A
Other languages
English (en)
Other versions
NO20002149L (no
Inventor
Vicki Coffin
Paul Glue
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20002149D0 publication Critical patent/NO20002149D0/no
Publication of NO20002149L publication Critical patent/NO20002149L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20002149A 1997-10-28 2000-04-27 FremgangsmÕte for Õ redusere avhengighet hos pattedyr NO20002149L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95921397A 1997-10-28 1997-10-28
PCT/US1998/022255 WO1999021540A2 (en) 1997-10-28 1998-10-26 Method of reducing craving in mammals

Publications (2)

Publication Number Publication Date
NO20002149D0 true NO20002149D0 (no) 2000-04-27
NO20002149L NO20002149L (no) 2000-06-26

Family

ID=25501785

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002149A NO20002149L (no) 1997-10-28 2000-04-27 FremgangsmÕte for Õ redusere avhengighet hos pattedyr

Country Status (16)

Country Link
EP (1) EP1043980A2 (no)
JP (1) JP2001520989A (no)
KR (1) KR20010031470A (no)
CN (1) CN1283116A (no)
AR (1) AR015984A1 (no)
AU (1) AU1110099A (no)
BR (1) BR9814830A (no)
CA (1) CA2308453A1 (no)
CO (1) CO4970824A1 (no)
HU (1) HUP0100115A2 (no)
IL (1) IL135659A0 (no)
NO (1) NO20002149L (no)
PE (1) PE122299A1 (no)
SK (1) SK5812000A3 (no)
WO (1) WO1999021540A2 (no)
ZA (1) ZA989786B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410527B1 (en) * 1998-03-02 2002-06-25 Schering Corporation Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism
PE20000333A1 (es) * 1998-03-02 2000-05-13 Schering Corp Metodo para tratar desordenes compulsivos obsesivos, desordenes somatoformes, desordenes disociativos, desordenes al comer, desordenes de control de impulso y autismo
US6890951B2 (en) 1998-08-05 2005-05-10 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
US6541520B1 (en) 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
IL137937A0 (en) * 1999-08-27 2001-10-31 Pfizer Prod Inc A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
US6395783B1 (en) 2000-10-23 2002-05-28 Brookhaven Science Associates, Llc Treatment of PCP addiction and PCP addiction-related behavior
US6462084B1 (en) 2001-05-14 2002-10-08 Brookhaven Science Associates, Llc Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG
DE60231896D1 (de) 2001-11-05 2009-05-20 Krele Pharmaceuticals Llc Zusammensetzungen und verfahren zur erhöhung der compliance mit therapien unter verwendung von aldehyddehydrogenase-hemmern und zur behandlung von alkoholsmus
JP6355921B2 (ja) 2010-09-01 2018-07-11 トニックス ファーマスーティカルズ, インコーポレイテッドTONIX Pharmaceuticals, Inc. コカイン嗜癖の治療
AU2013289922B2 (en) 2012-07-12 2016-12-15 Psyadon Pharmaceuticals, Inc. Fused benzazepines for treatment of Tourette's Syndrome
SMT202000398T1 (it) * 2013-10-18 2020-09-10 Emalex Biosciences Inc Benzazepine fuse per il trattamento della balbuzie
CN110327350B (zh) * 2019-07-11 2021-02-23 温州医科大学 多巴胺d1受体拮抗剂sch39166在作为制备治疗眼部病理性血管新生药物的应用
CN110833621A (zh) * 2019-12-06 2020-02-25 中国医科大学 多巴胺受体1拮抗剂在制备治疗对氯胺酮致小鼠类精神分裂症药物上的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607967A (en) * 1994-10-27 1997-03-04 Merck & Co., Inc. Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan carboxylic acid
AU3408097A (en) * 1996-06-06 1998-01-05 Ergo Research Corporation Treatment of lipid and glucose metabolism disorders with dopamine and seroto nin agonists

Also Published As

Publication number Publication date
WO1999021540B1 (en) 1999-10-28
SK5812000A3 (en) 2000-12-11
HUP0100115A2 (hu) 2001-06-28
JP2001520989A (ja) 2001-11-06
NO20002149L (no) 2000-06-26
AR015984A1 (es) 2001-05-30
WO1999021540A3 (en) 1999-09-02
CA2308453A1 (en) 1999-05-06
AU1110099A (en) 1999-05-17
ZA989786B (en) 1999-04-28
EP1043980A2 (en) 2000-10-18
PE122299A1 (es) 1999-12-04
CN1283116A (zh) 2001-02-07
IL135659A0 (en) 2001-05-20
KR20010031470A (ko) 2001-04-16
WO1999021540A2 (en) 1999-05-06
CO4970824A1 (es) 2000-11-07
BR9814830A (pt) 2000-10-03

Similar Documents

Publication Publication Date Title
FI972024L (fi) Kanavanvaihtomenetelmä
FI962231A0 (fi) Traeskelarrangemang hos en hisskorg
DK0964665T3 (da) Fastgørelsesorgan til absorberende klædningsstykker
NO20002135D0 (no) Reflectometer
DE69806599D1 (de) Multipel-flammpunkt-verdampfungssystem
FI970036L (fi) Menetelmä toistimien hallintaan
DE59811445D1 (de) Synchronisiervorrichtung
ID23013A (id) Bahan-bahan farmakologi
NO20002149D0 (no) FremgangsmÕte for Õ redusere avhengighet hos pattedyr
IS5106A (is) Ný aðferð
DE69827000D1 (de) Neues verfahren
DE69832848D1 (de) SPS-Synchronisationsverfahren
DE69840366D1 (de) System zur probeentnahme
FI972108A7 (fi) Menetelmä parametrien siirtämiseksi
NO996254D0 (no) Fremgangsmåte for synkronisering
ID17067A (id) Metode tampilan sederhana untuk area penghubungan
DE69830461D1 (de) Synchronisationsvorrichtung für Dekoder
FI970793L (fi) Menetelmä kytkentöjen purkamiseksi
ID24110A (id) Pembuatan rutenium kompleks
DE59701604D1 (de) Synchronisationsverfahren
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod
FI973099A0 (fi) Installationsanordning hos balkongglasering
FI971230L (fi) Synkronointimenetelmä
NO964439D0 (no) For
FI970485A0 (fi) Styrsystem hos en inmatningsanordning av en harvestermaskin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application